Atlas Trials

Partial-Onset Seizures

26 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Partial-Onset Seizures

RecordFirmDate
A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy (NCT04252846)Eisai Limited2020-07-20
A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy (NCT04015141)Eisai Inc.2019-05-31
A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older (NCT03836924)Eisai Pharmaceuticals India Pvt. Ltd2019-02-18
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures (NCT03288129)Eisai Inc.2017-08-23
Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study) (NCT03201900)Eisai Co., Ltd.2017-06-28
A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy (NCT04230044)Eisai Co., Ltd.2016-04-11
Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy (NCT02736162)Eisai Inc.2016-04-01
A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures. (NCT02072824)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2014-09-16
Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures (NCT02192814)UCB Japan Co. Ltd.2014-06-01
A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures (NCT02124564)UCB Japan Co. Ltd.2014-04-01
Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures (NCT01832038)UCB Pharma SA2013-03-26
A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures (NCT01710657)UCB Pharma SA2012-09-01
A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures (NCT01618695)Eisai Co., Ltd.2012-05-15
A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS) (NCT01830400)Eisai Inc.2012-04-01
A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM) (NCT01830868)Eisai Inc.2012-03-01
An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy (NCT01506882)UCB Japan Co. Ltd.2011-12-01
An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures (NCT01407523)UCB Japan Co. Ltd.2011-07-01
Phase II BGG492 Capsule Extension for Partial Epilepsy (NCT01338805)Novartis Pharmaceuticals2011-06-01
Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures (NCT01167335)Novartis2010-08-01
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures (NCT01147003)Novartis2010-06-01
Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures (NCT01051193)Nobelpharma2010-01-05
Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures (NCT00975715)Novartis Pharmaceuticals2009-09-01
Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures (NCT00655486)UCB BIOSCIENCES, Inc.2008-04-01
Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures (NCT00655551)UCB BIOSCIENCES, Inc.2008-04-01
An Extended Access Program for Perampanel (NCT01871233)Eisai Inc.

Track Partial-Onset Seizures automatically

Every clearance here is in the API, with alerts when new ones post.